Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke.

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Traylor, Matthewca
  • dc.contributor.author Rost, Nataliaca
  • dc.contributor.author International Stroke Genetics Consortiumca
  • dc.date.accessioned 2016-01-29T07:44:39Z
  • dc.date.available 2016-01-29T07:44:39Z
  • dc.date.issued 2016
  • dc.description.abstract OBJECTIVE: For 3,670 stroke patients from the United Kingdom, United States, Australia, Belgium, and Italy, we performed a genome-wide meta-analysis of white matter hyperintensity volumes (WMHV) on data imputed to the 1000 Genomes reference dataset to provide insights into disease mechanisms. METHODS: We first sought to identify genetic associations with white matter hyperintensities in a stroke population, and then examined whether genetic loci previously linked to WMHV in community populations are also associated in stroke patients. Having established that genetic associations are shared between the 2 populations, we performed a meta-analysis testing which associations with WMHV in stroke-free populations are associated overall when combined with stroke populations. RESULTS: There were no associations at genome-wide significance with WMHV in stroke patients. All previously reported genome-wide significant associations with WMHV in community populations shared direction of effect in stroke patients. In a meta-analysis of the genome-wide significant and suggestive loci (p < 5 × 10(-6)) from community populations (15 single nucleotide polymorphisms in total) and from stroke patients, 6 independent loci were associated with WMHV in both populations. Four of these are novel associations at the genome-wide level (rs72934505 [NBEAL1], p = 2.2 × 10(-8); rs941898 [EVL], p = 4.0 × 10(-8); rs962888 [C1QL1], p = 1.1 × 10(-8); rs9515201 [COL4A2], p = 6.9 × 10(-9)). CONCLUSIONS: Genetic associations with WMHV are shared in otherwise healthy individuals and patients with stroke, indicating common genetic susceptibility in cerebral small vessel disease.ca
  • dc.description.sponsorship Funding for collection, genotyping, and analysis of stroke samples was provided by Wellcome Trust Case Control Consortium–2, a functional genomics grant from the Wellcome Trust (DNA-Lacunar), the Stroke Association (DNA-Lacunar), the Intramural Research Program of National Institute of Ageing (Massachusetts General Hospital [MGH] and Ischemic Stroke Genetics Study [ISGS]), National Institute of Neurological Disorders and Stroke (Siblings With Ischemic Stroke Study, ISGS, and MGH), the American Heart Association/Bugher Foundation Centers for Stroke Prevention Research (MGH), Deane Institute for Integrative Study of Atrial Fibrillation and Stroke (MGH), National Health and Medical Research Council (Australian Stroke Genetics Collaborative), and Italian Ministry of Health (Milan). Additional support for sample collection came from the Medical Research Council, National Institute of Health Research Biomedical Research Centre and Acute Vascular Imaging Centre (Oxford), Wellcome Trust and Binks Trust (Edinburgh), and Vascular Dementia Research Foundation (Munich). M.T. is supported by a project grant from the Stroke Association (TSA 2013/01). H.S.M. is supported by an NIHR Senior Investigator award. H.S.M. and S.B. are supported by the NIHR Cambridge University Hospitals Comprehensive Biomedical Research Centre. V.T. and R.L. are supported by grants from FWO Flanders. P.R. holds NIHR and/nWellcome Trust Senior Investigator Awards. P.A.S. is supported by an MRC Fellowship. C.M.L.’s research is supported by the National Institute for Health Research Biomedical Research Centre (BRC) based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, and the BRC for Mental Health at South London and Maudsley NHS Foundation Trust and King’s College London.
  • dc.format.mimetype application/pdfca
  • dc.identifier.citation Traylor M, Zhang CR, Adib-Samii P, Devan WJ, Parsons OE, Lanfranconi S. et al. Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke. Neurology. 2016 Jan 12;86(2):146-53. doi: 10.1212/WNL.0000000000002263.ca
  • dc.identifier.doi http://dx.doi.org/10.​1212/​WNL.​0000000000002263
  • dc.identifier.issn 0028-3878
  • dc.identifier.uri http://hdl.handle.net/10230/25696
  • dc.language.iso engca
  • dc.publisher American Academy of Neurologyca
  • dc.relation.ispartof Neurology. 2016 Jan 12;86(2):146-53
  • dc.rights © 2015 American Academy of Neurology. This is an open access article distributed under the terms of the http://creativecommons.org/licenses/by/4.0/ (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.ca
  • dc.rights.accessRights info:eu-repo/semantics/openAccessca
  • dc.rights.uri http://creativecommons.org/licenses/by/4.0/ca
  • dc.subject.other Malalties cerebrovascularsca
  • dc.title Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke.ca
  • dc.type info:eu-repo/semantics/articleca
  • dc.type.version info:eu-repo/semantics/publishedVersionca